--- name: review-term-sheet-investor-side-sboghossian title: Term Sheet Review — Investor Side description: Use when reviewing a VC or angel investor term sheet from the investor's perspective. Flags gaps in downside protection, control rights, information access, and founder accountability. Covers liquidation preference adequacy, anti-dilution minimums, board composition, protective provisions, pay-to-play, founder vesting and IP assignment, exclusivity, and deal-killer scenarios. Applies MENA and international VC market standards (DIFC, ADGM, KSA, US, UK). author: sboghossian author_url: https://github.com/sboghossian/mini-claude-for-legal/tree/main/skills/review/review-term-sheet-investor-side license: MIT version: 0.1.0 execution_mode: open jurisdiction: general practice: corporate language: en --- # Term Sheet Review — Investor Side ## When to use this Use when a VC fund, family office, or angel investor needs to review a term sheet (whether drafted by them or by the company's lawyers) from the investor's perspective. The investor's goals are: downside protection (liquidation preference, anti-dilution), governance rights (board seat, protective provisions, information rights), accountability mechanisms (founder vesting, IP assignment), and exit alignment (drag-along, ROFR, co-sale). For the founder-side perspective, use [[review-term-sheet-founder-side]]. ## Inputs | Input | Why it matters | Default | |---|---|---| | Term sheet | Full document | Required | | Investment stage | Seed, Series A, B — calibrates market standard | Ask if unclear | | Investment size and target ownership | Determines whether protective provisions match stake | From term sheet | | Jurisdiction | Company registration jurisdiction affects enforceability | From term sheet | | Prior rounds | Existing cap table and any senior security holders | Ask if available | ## Review Methodology ### 1. Liquidation Preference — Adequacy The liquidation preference determines investor return in a sale, wind-down, or distribution event. **Minimum acceptable**: 1× non-participating — investor gets back invested capital (or pro-rata proceeds if higher) before any distribution to common. This is the market floor for institutional investors. **Stage-appropriate expectations**: | Stage | Acceptable preference | |---|---| | Pre-seed / angel | 1× non-participating is standard; sometimes 1.25× or 1.5× for high-risk early cheques | | Seed | 1× non-participating; some seed investors negotiate participating with 2× cap | | Series A / B | 1× non-participating is strong market standard; participating is increasingly rare | | Late stage (distressed) | 1× or 2× participating may be appropriate given risk profile | **Flag**: - 1× non-participating with no cap on distribution proceeds — investor misses growth upside in a pure exit scenario; check whether preferred converts to common for IPO/high-value exits (standard) - Liquidation preference applies on IPO — generally unacceptable; preferred should convert to common upon IPO ### 2. Anti-Dilution — Minimum Standard **Acceptable minimum**: broad-based weighted-average anti-dilution. Any round that provides less protection than this is a deal-killer for institutional investors. **What to verify**: - Is the formula clearly specified? (Not just "weighted average" — verify it is "broad-based weighted average" incorporating all shares outstanding including option pool) - Are carve-outs appropriate? (Anti-dilution should not be triggered by: option pool shares; conversion of existing convertible notes; shares issued as M&A consideration; certain lender warrants) - Is the anti-dilution protection automatically applied or does it require shareholder approval? (Auto-apply is investor-protective) **Red flag**: company proposing a narrow-based weighted-average (only shares of the same series) — provides less protection than broad-based. Reject. ### 3. Board Composition **Minimum for lead investor** (Series A, 15–30% ownership): - 1 board seat for the lead investor - Observer right (no voting) for follow-on investors or co-investors who did not lead **Acceptable early-stage structure**: - 2 founder seats - 1 investor seat - 1 independent seat (investor has meaningful role in independent director selection) **Flag**: - No board seat for the lead investor on a significant round — unacceptable for institutional Series A+ - Independent director can be removed by founder majority without investor consent — weakens governance - No mechanism for investor to appoint additional board members as investor's ownership percentage grows (e.g., if anti-dilution triggers additional shares) ### 4. Protective Provisions — Coverage Protective provisions are investor veto rights over specific company actions. A complete list for institutional investors: **Core protective provisions** (non-negotiable): - Sale of the company (merger, acquisition, asset sale, change of control) - Issuance of any new class of security ranking senior to or pari passu with investor's preferred series - Amendment to articles/charter that adversely affects the investor's preferred series - Taking on financial indebtedness above a specified threshold (typically USD 500K to USD 2M depending on stage) - Any material change in the nature of the company's principal business - M&A transactions above a specified value - IPO or public listing (to protect investor's preferences / conversion mechanics) **Additional protective provisions** (common but often negotiated): - Issuance of any new equity beyond the reserved option pool - Entry into any joint venture or partnership - Licensing of core IP on an exclusive basis - Related-party transactions above a defined threshold **Flag**: - Protective provisions that require a simple majority of preferred to exercise — should require the lead investor's specific consent to avoid being overridden by small holders of preferred - Missing any of the core provisions above - Protective provisions that sunset after a defined period (unusual; flag) ### 5. Information Rights Investors need visibility into the company's performance to manage their portfolio and meet their own fund reporting obligations. **Standard investor information rights**: | Right | Frequency | Notes | |---|---|---| | Management accounts / financials | Monthly | P&L, cash position, KPIs | | Annual audited financial statements | Annually | Required by most LP agreements | | Annual budget and operating plan | Annually before fiscal year start | Right to provide input; not right to approve | | Notification of material events | Promptly | Litigation, regulatory action, loss of major customer | | Access to management team | Reasonable | For due diligence follow-up; not unrestricted | | Cap table and option pool updates | On any change | Investor needs to track dilution | **Flag**: - Monthly management accounts absent — investor is flying blind - Information rights limited to annual audited accounts only — inadequate for active portfolio management - Budget review right absent — investor cannot anticipate cash needs or track against plan - No notification obligation for material events (litigation, regulatory action, insolvency risk) **MENA context**: Gulf-based family offices may be less demanding on monthly management accounts; institutional GPs and LPs expect them. Calibrate against fund type. ### 6. Pro-Rata Rights The right to participate in future funding rounds to maintain ownership percentage. **Standard**: pro-rata right through at least Series B (or through all rounds for lead investors). **Variants**: - Super pro-rata: right to invest more than one's ownership percentage in future rounds — often contested by founders - Pro-rata notification requirement: company must notify investor of forthcoming round sufficiently in advance for investor to participate **Flag**: no pro-rata right at all for a meaningful ownership stake investor — creates unacceptable dilution risk. ### 7. Pay-to-Play Pay-to-play provisions require existing investors to participate in follow-on rounds (at least pro-rata) or face consequences: - **Light pay-to-play**: preferred converts to common (loses economic preference) if investor does not participate - **Heavy pay-to-play**: preferred converts to ordinary shares and loses all protective provisions and board rights **Investor's perspective**: - Pay-to-play is acceptable as a company-protection mechanism to ensure pro-rata participation from early investors in difficult rounds - However, investor should ensure the pay-to-play trigger has a minimum round size threshold (does not apply to small bridge rounds or insider rounds) - Ensure there is a 30-60 day notice period before the pay-to-play obligation crystallizes ### 8. Drag-Along — Investor Alignment **Minimum drag-along structure from investor's perspective**: - Investor (as preferred holder) is part of the majority that can trigger drag-along - Drag-along applies to all shareholders including founders (prevents a minority of founders blocking a value-creating exit) - Drag threshold: majority of preferred + majority of common + board approval (prevents investor dragging without board support) **Flag**: - No drag-along at all — founders can block a sale that the investor wants - Drag-along requires all-holders consent — unanimity is unworkable for exits - Drag threshold set so high that it is practically unusable (e.g., 90% of all shares) ### 9. Founder Vesting and IP Assignment **Required from investor's perspective**: - **Founder vesting**: 4-year, 1-year cliff; unvested shares subject to company repurchase right at cost if founder departs without cause. This protects the company (and therefore investors) from a founder walking away with a large unearned equity stake. - **Double-trigger acceleration**: acceptable; single-trigger acceleration is a red flag — means a founder gets full equity on any acquisition regardless of whether they continue post-CiC - **IP assignment**: all founders must have assigned all company-related IP to the company, including pre-incorporation work and work done on personal equipment. A missing IP assignment can affect the company's ability to raise future rounds or achieve a clean exit. **Flag**: - No founder vesting (founders already fully vested pre-investment) without a vesting restart on acceptable terms - Single-trigger acceleration on CiC — investor pays for future value; founder captures it on day one of a CiC - IP assignment incomplete or missing ### 10. Exclusivity, Fees, and Longstop **Standard**: - Exclusivity: 30–60 days; should not exceed 90 days without milestone-based extension - Legal fees: company pays investor's legal fees up to a cap (USD 25–50K for Series A; USD 75–150K for Series B+) - Longstop: if definitive documents are not signed within 90 days of term sheet, term sheet expires **Flag**: - No longstop date — deal drags indefinitely, investor is in limbo - No legal fee reimbursement — unusual for institutional investors - Exclusivity with no termination right for investor — investor cannot exit the process if diligence reveals problems ## Deal Killers — Walk-Away Scenarios | Issue | Why it is a deal-killer | |---|---| | No founder vesting | Investor is funding founders who can walk away fully vested immediately | | Full ratchet anti-dilution offered to existing holders senior to this round | Investor's new money may trigger catastrophic dilution from existing full-ratchet holders | | IP chain of title broken | Company may not own its core assets | | No protective provisions at all | Investor has no governance control over material company decisions | | Founders hold a blocking minority on all key votes | Investor cannot enforce any governance rights | ## Output Format ```json { "findings": [ { "provision": "
", "issue": "", "severity": "critical|high|medium|low", "market_standard": "", "recommended_redline": "" } ], "deal_killers": [""], "overall_investor_protection": "strong|adequate|weak|unacceptable", "priority_redlines": [""] } ``` ## Related Skills - [[review-term-sheet-founder-side]] - [[review-msa-deep-review]] - [[review-unusual-terms-detector]] - [[draft-sha]] - [[draft-safe-note]] - [[review-ip-ownership-clarity]]